Valuation: BOIRON

Market Cap 323M 363M 299M 272M 514M 34.48B 522M 3.6B 1.41B 17.99B 1.36B 1.33B 57.36B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 275M 309M 255M 232M 438M 29.37B 445M 3.06B 1.2B 15.33B 1.16B 1.14B 48.86B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day+3.91%
1 week+5.68%
Current month-7.00%
1 month-26.19%
3 months-30.60%
6 months-26.19%
Current year-38.61%
1 week 16.9
Extreme 16.9
19.5
1 month 16.9
Extreme 16.9
21.5
Current year 16.9
Extreme 16.9
30.95
1 year 16.9
Extreme 16.9
32.25
3 years 16.9
Extreme 16.9
43.96
5 years 16.9
Extreme 16.9
56.5
10 years 16.9
Extreme 16.9
92.7
Manager TitleAgeSince
Chief Executive Officer 57 31/12/2024
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 31/12/2021
Director TitleAgeSince
Chairman 65 30/06/2011
Director/Board Member 54 09/03/2010
Director/Board Member 51 22/05/2013
Date Insider Type Main position Quantity % Market Cap. Importance
29/10/23 Sell

Director

198,664 1.1323%
29/10/23 Sell

Director

462,964 2.6387%
29/10/23 Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
+3.91%+5.68%-32.36%-64.57% 363M
+0.43%+6.59%+56.57%+106.64% 1,120B
+0.90%-2.25%+32.26%+63.73% 616B
+0.71%+3.24%+24.33%+91.33% 504B
-0.13%+5.98%+33.66%+50.18% 367B
+0.52%+0.24%+72.13%+40.11% 360B
-0.95%+4.70%+19.65%+42.71% 288B
-1.98%+3.73%-0.89%+10.43% 258B
-0.35%+4.25%+44.74%+52.06% 234B
-0.75%+3.32%+27.18%+94.07% 194B
Average +0.23%+3.82%+27.73%+48.67% 394.13B
Weighted average by Cap. +0.13%+3.83%+39.33%+71.81%

Financials

2024 2025
Net sales 488M 548M 452M 411M 776M 52.06B 788M 5.43B 2.13B 27.17B 2.06B 2.01B 86.6B 501M 564M 464M 423M 797M 53.5B 810M 5.58B 2.19B 27.92B 2.12B 2.07B 89B
Net income 11.34M 12.75M 10.51M 9.56M 18.04M 1.21B 18.33M 126M 49.52M 632M 47.86M 46.84M 2.01B 32.64M 36.72M 30.26M 27.53M 51.95M 3.49B 52.78M 364M 143M 1.82B 138M 135M 5.8B
Net Debt -49.74M -55.95M -46.1M -41.94M -79.15M -5.31B -80.42M -554M -217M -2.77B -210M -206M -8.83B -47.86M -53.84M -44.36M -40.36M -76.15M -5.11B -77.37M -533M -209M -2.67B -202M -198M -8.5B
Projected Income Statement - Annual - BOIRON
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,623
Date Price Change Volume
16/10/26 €18.60 +3.91% 9,099
15/10/26 €17.90 -0.56% 5,955
14/10/26 €18.00 +6.51% 4,223
13/10/26 €16.90 -2.03% 13,940
12/10/26 €17.25 -1.99% 7,127

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - BOIRON